Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September 2024 as against Rs 89.25 crore during the previous quarter ended September 2023. Sales declined 25.59% to Rs 310.84 crore in the quarter ended September 2024 as against Rs 417.75 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales310.84417.75 -26 OPM %20.0232.91 - PBDT65.50136.10 -52 PBT49.42121.59 -59 NP32.8489.25 -63 Powered by Capital Market - Live News

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024.Powered by Capital Market - Live News

Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as against Rs 61.88 crore during the previous quarter ended June 2023. Sales rose 21.11% to Rs 439.60 crore in the quarter ended June 2024 as against Rs 362.99 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales439.60362.99 21 OPM %28.0626.70 - PBDT125.4996.75 30 PBT109.2183.16 31 NP97.8761.88 58 Powered by Capital Market - Live News

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live News

Neuland Laboratories announced that the 40th Annual General Meeting(AGM) of the company will be held on 31 July 2024.Powered by Capital Market - Live News